Table 1.
Number of cases | 39 | Cervical cytology, No (%) | |||
---|---|---|---|---|---|
Positive | 19 | (61.3) | |||
Age Mets (years) | Negative | 12 | (38.7) | ||
Median | 44 | Not reported | 8 | ||
Range | 23–75 | ||||
Histology of metastatic cervical tumor, No (%) | |||||
Metastatic sites documented (36 cases), No. (%) | SRC | 22 | (64.7) | ||
Ovary | 27 | (75.0) | PD | 7 | (20.6) |
Peritoneum | 12 | (33.3) | UD | 1 | (2.9) |
Douglas mass | 8 | (22.2) | UD + SRC | 3 | (8.8) |
Cervix alone | 2 | (5.5) | PD + tubular | 1 | (2.9) |
Not reported | 5 | ||||
Clinical stage of the primary gastric cancer, No (%) | |||||
I | 1 | (5.3) | P/M Interval (months) | ||
II | 0 | Median | 22 | ||
III | 0 | Range | 1–121 | ||
IV | 18 | (94.7) | |||
Not reported | 20 | Survival (months) | |||
Dead (25 cases) | |||||
Symptoms, No (%) | Median | 4 | |||
Atypical genital bleeding | 14 | (35.8) | Range | 0–33 | |
Abdominal pain | 8 | (20.5) | Alive (8 cases) | ||
Abdominal mass | 4 | (10.2) | Median | 4 | |
Other | 8 | (20.5) | Range | 1–8 | |
No symptom | 2 | (5.1) | Not reported (6 cases) |
Metastatic sites included multiple cases. Cervical cytology positive; cancer cells or atypical cells were observed. SRC, signet ring cells; PD, poorly differentiated; UD, undifferentiated. P/M interval; interval between the diagnosis of primary gastric cancer and metastatic cervical tumor in 22 recurrent cases.